Arrayjet is a leading microarray company that provides solutions to researchers and development groups across academia, biotechnology, pharma and diagnostics.
Our patented inkjet platform combines the fastest and most reliable bioprinting instruments with the versatility to print any biological sample type onto any solid substrate. Applications range from antibody characterisation to gene expression profiling and small molecule screening. We use our in-house application and engineering expertise to collaborate with customers for novel application development, assay optimisation, scaling-up and commercial manufacture.
Our operations are based out of our ISO13485:2016 accredited facility in Edinburgh, Scotland.
Arrayjet Ltd was established in 2000 with private equity from Archangel Investors Ltd and the Scottish Government. The company developed and patented an inkjet technology to print biological samples onto solid substrates and create microarrays. Arrayjet is at the global forefront of this field and has installed instruments throughout 5 continents since commercialisation in 2006.
In 2011 Arrayjet Advance™ was launched to offer contract research and contract manufacturing services. In 2021 we launched operations in the USA with the formation of Arrayjet Inc.
